Nicholas Nissen
Overview
Explore the profile of Nicholas Nissen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
793
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaur B, Yeo Y, Liang J, Luu M, Ayoub W, Kuo A, et al.
Gastro Hep Adv
. 2024 Aug;
3(2):230-237.
PMID: 39129956
Background And Aims: The change in hepatocellular carcinoma (HCC) care continuum during the coronavirus disease 2019 (COVID-19) pandemic remains unknown at a national level in the United States. We sought...
2.
Liang J, Li P, Norman J, Lauzon M, Yeo Y, Trivedi H, et al.
Hepatol Commun
. 2024 Jun;
8(7).
PMID: 38896084
Background: Serum AFP-L3%, AFP, and DCP are useful biomarkers for HCC detection, but their utility in assessing treatment response remains unknown. We aim to evaluate the accuracy of a biomarker...
3.
Liang J, Lee Y, Yeo Y, Luu M, Ayoub W, Kuo A, et al.
Clin Transl Gastroenterol
. 2024 Jun;
15(7):e00723.
PMID: 38829967
Introduction: Access to hepatocellular carcinoma (HCC) surveillance and treatments were disrupted during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to characterize the impact of the pandemic on HCC incidence...
4.
Wang J, Cui Y, Osipov A, Gong J, Pandol S, Lo S, et al.
Clin Transl Gastroenterol
. 2024 Jun;
15(7):e00719.
PMID: 38822798
Introduction: Pancreatic ductal adenocarcinoma is associated with significant morbidity and mortality as most patients present with advanced disease. The development of ascites has been associated with poor outcomes and further...
5.
Russo A, DiPeri T, Dumitra T, Tseng J, Pletcher E, Justo M, et al.
J Neuroendocrinol
. 2024 May;
36(8):e13399.
PMID: 38760997
Patients with gastroenteropancreatic (GEP) neuroendocrine tumors (NET) often present with advanced disease. Primary tumor resection (PTR) in the setting of unresectable metastatic disease is controversial. Most studies evaluating the impact...
6.
Shishido S, Lin E, Nissen N, Courcoubetis G, Suresh D, Mason J, et al.
NPJ Precis Oncol
. 2024 Feb;
8(1):36.
PMID: 38360856
Pancreatic ductal adenocarcinoma (PDAC) has a five-year survival rate of less than 10% due to its late diagnosis, rapid metastasis, and chemotherapeutic resistance. For a small proportion (10-20%) of early-stage...
7.
Gonzalez-Mancera M, Siref A, Kosari K, Nissen N, Gaddam S, Hendifar A, et al.
Am J Clin Pathol
. 2024 Feb;
162(1):41-50.
PMID: 38345293
Objectives: Adenocarcinomas of the biliary tract frequently present diagnostic challenges because of their histologic overlap with benign and preinvasive lesions. The molecular profiles of biliary adenocarcinomas vary by anatomical location....
8.
Yeo Y, Liang J, Lauzon M, Luu M, Noureddin M, Ayoub W, et al.
Am J Gastroenterol
. 2023 Aug;
118(12):2201-2211.
PMID: 37561061
Introduction: The efficacy and safety of combined immunotherapy and transarterial radioembolization (TARE) were suggested in preclinical and early-phase trials, but these were limited by small sample sizes. We sought to...
9.
Rosenzweig A, Berlin J, Chari S, Kindler H, Matrisian L, Mayoral A, et al.
Oncologist
. 2023 Apr;
28(7):584-595.
PMID: 37043728
Pancreatic cancer is one of the few cancer types in the US with incidence and death rates continuing to rise. As the disease threatens to become the second leading cause...
10.
Jordan S, Balzer B, Nast C, Atienza J, Lim K, Kumar S, et al.
Clin Case Rep
. 2023 Mar;
11(2):e6998.
PMID: 36860726
Linear IgA bullous dermatosis (LABD) is a rare autoimmune/inflammatory skin condition. Here, we report on a patient who developed treatment resistant LABD. At diagnosis, elevations of IL-6 and C-reactive protein...